ADJUVANT FOR MUCOSAL VACCINE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150306214A1
SERIAL NO

14649279

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An object of the present invention is to provide an adjuvant for a mucosal vaccine with high safety that induces a sufficient immune response on the mucosa. According to the present invention, an adjuvant for a mucosal vaccine comprising a protein complex composed of hemagglutinin (HA) subcomponents HA1, HA2, and HA3 of botulinum toxin is provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
OSAKA UNIVERSITYSUITA
DAIICHI SANKYO COMPANY LIMITED3-5-1 NIHONBASHI HONCHO CHUO-KU TOKYO 103-8426

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fujinaga, Yukako Osaka, JP 8 17
Jonai, Nao Tokyo, JP 9 10
Matsumura, Takuhiro Osaka, JP 3 8
Yutani, Masahiro Osaka, JP 3 8

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation